Every Capital PTY
.svg)
Adelaide, AustraliaInvestor highlights
- Industry focus
- Geo focus
Discover reliable insights
Find relevant VC investors, identify key contacts and secure funding opportunities.
Investments analytics
Analytics
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Neuron23 | Jun 25, 2025 | Artificial Intelligence, Biotechnology, Machine Learning, Neurodegenerative Diseases, Neuroinflammatory Diseases, Systemic Autoimmune and Inflammatory Diseases | - | 96500000 USD |  San Francisco, California |
| Latigo Biotherapeutics | Mar 17, 2025 | Artificial Intelligence, Biotechnology, Nav1.8 inhibitor, Non-opioid pain medicines, Non-opioid Pain Medicines, Non-opioid pain treatments, Pain medicines | - | 150000000 USD | Thousand Oaks, California |
| Latigo Biotherapeutics | Feb 14, 2024 | Artificial Intelligence, Biotechnology, Nav1.8 inhibitor, Non-opioid pain medicines, Non-opioid Pain Medicines, Non-opioid pain treatments, Pain medicines | Early stage | 135000000 USD | Thousand Oaks, California |
| Immaterial | Sep 21, 2023 | Advanced materials, Advanced Materials, Carbon capture, Carbon Capture, Cleantech, Hydrogen storage, Hydrogen Storage, Metal-organic frameworks, Systems design | Early stage | - |  Cambridge, England |
| Kate Therapeutics | Aug 6, 2023 | AAV-based Gene Therapies, Adeno-Associated Virus (AAV), Biotechnology, Gene Therapy, Muscle and Heart Diseases, Patient-Centric | Early stage | 51000000 USD | San Diego, California |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.